128 related articles for article (PubMed ID: 1958450)
1. The pharmacokinetics of oxycodone after intravenous injection in adults.
Pöyhiä R; Olkkola KT; Seppälä T; Kalso E
Br J Clin Pharmacol; 1991 Oct; 32(4):516-8. PubMed ID: 1958450
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects.
Pöyhiä R; Seppälä T; Olkkola KT; Kalso E
Br J Clin Pharmacol; 1992 Jun; 33(6):617-21. PubMed ID: 1389934
[TBL] [Abstract][Full Text] [Related]
3. Elimination of intravenous oxycodone in the elderly: a pharmacokinetic study in postoperative orthopaedic patients of different age groups.
Liukas A; Kuusniemi K; Aantaa R; Virolainen P; Neuvonen M; Neuvonen PJ; Olkkola KT
Drugs Aging; 2011 Jan; 28(1):41-50. PubMed ID: 21174486
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone.
Kaiko RF; Benziger DP; Fitzmartin RD; Burke BE; Reder RF; Goldenheim PD
Clin Pharmacol Ther; 1996 Jan; 59(1):52-61. PubMed ID: 8549034
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat.
Chan S; Edwards SR; Wyse BD; Smith MT
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):295-302. PubMed ID: 17973932
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of oxycodone hydrochloride and three of its metabolites after intravenous administration in Chinese patients with pain.
Hao GT; Zhou HY; Gao HZ; Qu HY; Liang YG; Li YY; Dong RH; Zhang LJ; Wang XF; Liu ZY
Pharmacol Rep; 2014 Feb; 66(1):153-8. PubMed ID: 24905321
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantation.
Kirvela M; Lindgren L; Seppala T; Olkkola KT
J Clin Anesth; 1996 Feb; 8(1):13-8. PubMed ID: 8695073
[TBL] [Abstract][Full Text] [Related]
8. The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissue.
Boström E; Jansson B; Hammarlund-Udenaes M; Simonsson US
Rapid Commun Mass Spectrom; 2004; 18(21):2565-76. PubMed ID: 15468158
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessions.
Leuppi-Taegtmeyer A; Duthaler U; Hammann F; Schmid Y; Dickenmann M; Amico P; Jehle AW; Kalbermatter S; Lenherr C; Meyer Zu Schwabedissen HE; Haschke M; Liechti ME; Krähenbühl S
Nephrol Dial Transplant; 2019 Apr; 34(4):692-702. PubMed ID: 30189012
[TBL] [Abstract][Full Text] [Related]
10. Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone.
Saari TI; Grönlund J; Hagelberg NM; Neuvonen M; Laine K; Neuvonen PJ; Olkkola KT
Eur J Clin Pharmacol; 2010 Apr; 66(4):387-97. PubMed ID: 20076952
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and ventilatory effects of intravenous oxycodone in postoperative children.
Olkkola KT; Hamunen K; Seppälä T; Maunuksela EL
Br J Clin Pharmacol; 1994 Jul; 38(1):71-6. PubMed ID: 7605420
[TBL] [Abstract][Full Text] [Related]
12. Grapefruit juice enhances the exposure to oral oxycodone.
Nieminen TH; Hagelberg NM; Saari TI; Neuvonen M; Neuvonen PJ; Laine K; Olkkola KT
Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):782-8. PubMed ID: 20406214
[TBL] [Abstract][Full Text] [Related]
13. Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients.
Andreassen TN; Klepstad P; Davies A; Bjordal K; Lundström S; Kaasa S; Dale O
Eur J Clin Pharmacol; 2011 May; 67(5):493-506. PubMed ID: 21140139
[TBL] [Abstract][Full Text] [Related]
14. Oxycodone concentrations in the central nervous system and cerebrospinal fluid after epidural administration to the pregnant ewe.
Kinnunen M; Kokki H; Hautajärvi H; Lantto J; Räsänen J; Voipio HM; Kokki M
Basic Clin Pharmacol Toxicol; 2019 Nov; 125(5):430-438. PubMed ID: 31222944
[TBL] [Abstract][Full Text] [Related]
15. Oxycodone pharmacokinetics and fetal exposure after intravenous or epidural administration to the ewe.
Kinnunen M; Kokki H; Hautajärvi H; Huhta H; Ranta VP; Räsänen J; Voipio HM; Kokki M
Acta Obstet Gynecol Scand; 2018 Oct; 97(10):1200-1205. PubMed ID: 29772054
[TBL] [Abstract][Full Text] [Related]
16. Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone.
Nieminen TH; Hagelberg NM; Saari TI; Pertovaara A; Neuvonen M; Laine K; Neuvonen PJ; Olkkola KT
Anesthesiology; 2009 Jun; 110(6):1371-8. PubMed ID: 19417618
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the pharmacokinetics of oxycodone and noroxycodone in male dark agouti and Sprague--Dawley rats: influence of streptozotocin-induced diabetes.
Huang L; Edwards SR; Smith MT
Pharm Res; 2005 Sep; 22(9):1489-98. PubMed ID: 16132361
[TBL] [Abstract][Full Text] [Related]
18. Cancer cachexia raises the plasma concentration of oxymorphone through the reduction of CYP3A but not CYP2D6 in oxycodone-treated patients.
Naito T; Tashiro M; Ishida T; Ohnishi K; Kawakami J
J Clin Pharmacol; 2013 Aug; 53(8):812-8. PubMed ID: 23733622
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of oxycodone after intravenous, buccal, intramuscular and gastric administration in children.
Kokki H; Rasanen I; Reinikainen M; Suhonen P; Vanamo K; Ojanperä I
Clin Pharmacokinet; 2004; 43(9):613-22. PubMed ID: 15217304
[TBL] [Abstract][Full Text] [Related]
20. Comparative oxycodone pharmacokinetics in humans after intravenous, oral, and rectal administration.
Leow KP; Smith MT; Watt JA; Williams BE; Cramond T
Ther Drug Monit; 1992 Dec; 14(6):479-84. PubMed ID: 1485370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
